Gilead’s $567 Million Acquisition of Cell Design Labs

Citi acted as financial advisor and Cooley LLP acted as legal advisor to Cell Design Labs in connection with the transaction.

Cell Design Labs, Inc., a privately-held biotechnology company developing disruptive CAR-T and T cell receptor (TCR) therapies, announced today that Gilead Sciences (Nasdaq:GILD) has agreed to acquire Cell Design Labs in a structured buy out valued for up to $567 million, including the shares of Cell Design Labs held by Kite.

Since its founding in 2016, Cell Design Labs has raised $34.4 million. Cell Design Labs’ investors, led by Kleiner Perkins, also included Kite, Osage Ventures, Mission Bay Ventures, Brian Atwood, President, Chief Executive Officer and Co-Founder of Cell Design Labs, Kite founder and member of the Cell Design Labs Board of Directors, Arie Belldegrun, M.D., as well as other investors with significant experience in biopharmaceutical innovation.

Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies. Based on innovative research from Dr. Wendell Lim’s lab at UC San Francisco, Cell Design Labs leverages the power of the body’s immune system to develop smart living therapies. Initially focused on cancer, including both hematologic and solid tumors, this broad technology may also have applications in other complex diseases.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Cooley advised with a team led by Ben Beerle and Jamie Leigh (Picture).

Involved fees earner: Ben Beerle – Cooley LLP; Jamie Leigh – Cooley LLP; Danielle Naftulin – Cooley LLP; Rishab Kumar – Cooley LLP; Allison Peth – Cooley LLP; Kate Hillier – Cooley LLP; Robert Jones – Cooley LLP; Natasha Leskovsek – Cooley LLP; Barbara Kosacz – Cooley LLP; Lisette Sell – Cooley LLP; Renee Deming – Cooley LLP; Alyssa Ohanian – Cooley LLP; Joshua Mates – Cooley LLP; Mark Windfeld-Hansen – Cooley LLP; Stephanie Gentile – Cooley LLP; Amanda Pacheco – Cooley LLP; Jacqueline Grise – Cooley LLP; Tanisha James – Cooley LLP; Katie Stork – Cooley LLP;

Law Firms: Cooley LLP;

Clients: Cell Design Labs Inc.;

Print Friendly, PDF & Email

Author: Ambrogio Visconti